2/15 RegenMD

RegenMD         bioMD makes offer for Allied Medical February 14, 2011 at 8:44 PM   bioMD Limited (ASX: BOD), a company with assets in regenerative tissue engineering technologies today announced that it has made an offer to buy all of the ... See all stories on this topic »         MPs to quiz Pfizer about axed R&D site February 14, 2011 at 12:35 PM   ... Ruth McKernan, head of the Sandwich site and a chief scientific officer for Pfizer regenerative medicine, and Richard Blackburn, the managing director ... See all stories on this topic »         Stem cell transplants help kidney damage February 14, 2011 at 11:42 AM   "Advancements in stem cell therapies and tissue engineering hold great promise for regenerative nephrology," said Dr. Abdol-Mohammad Kajbafzadeh, ... See all stories on this topic »         BioTime expands research capabilities with Glycosan BioSystems purchase February 14, 2011 at 11:42 AM   Glycosan, which was founded in 2006, develops and manufactures hyrdogel products used for tissue engineering and reconstruction, or for research involving ... See all stories on this topic » Proactive Investors USA & Canada         Going 'green' in LA February 14, 2011 at 10:13 AM   By Jeff Dankert Stacey Hooper, an architectural designer in Los Angeles, helped design the Eli and Edythe Broad Cirm Center for Regenerative Medicine and ... See all stories on this topic » LaSalle News Tribune         Cephalon buys stake in regenerative medicine firm February 14, 2011 at 10:13 AM   Mesoblast Ltd., an Australian regenerative medicine company, said Monday it has issued a 24,7 million shares of stock to Cephalon Inc. under the terms of a ... See all stories on this topic »         BioTime Announces Agreement To Acquire Glycosan BioSystems February 14, 2011 at 10:13 AM   Regenerative medicine refers to the development and use of therapies based on human embryonic stem (hES) cell or induced pluripotent stem (iPS) cell ... See all stories on this topic »         Mending Broken Hearts February 14, 2011 at 10:13 AM   According to a new research, there has been the discovery of using regenerative medicine for repairing the damaged hearts of patients. ... See all stories on this topic » TopNews United States         BioTime Announces Agreement To Acquire Glycosan BioSystems February 14, 2011 at 9:45 AM   "The founding scientists of Glycosan have been pioneers in the field of tissue engineering," said Michael D. West, Ph.D., President and Chief Executive ... See all stories on this topic »         Hospital backs project to repair damaged hearts February 14, 2011 at 5:38 AM   To try to address this, the BHF has unveiled a major new programme of research in regenerative medicine to repair damaged hearts. The Mending Broken Hearts ... See all stories on this topic »         Mesoblast issues $139 million in stock to Cephalon February 13, 2011 at 8:36 PM   Regenerative medicine specialists Mesoblast plans to diversify its product offerings in adult stem cells funded by an additional $139 million in cash raised ... See all stories on this topic »             This email was sent to regenmd@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here